Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings

P. VICKERMAN ; N. MARTIN ; K. TURNER ; M. HICKMAN | 2012
Dans Addiction (Vol.107, n°11, November 2012) Article : Périodique

Aims: To investigate the impact of scaling-up opiate substitution therapy (OST) and high coverage needle and syringe programmes (100%NSP - obtaining more sterile syringes than you inject) on HCV prevalence among injecting drug users (IDUs). De[...]

Plus d'info

Ajouter à la sélection

Lien externe

Changing risky drinking practices in different types of social worlds: concepts and experiences

R. ROOM ; S. MACLEAN ; A. PENNAY ; R. DWYER ; K. TURNER ; E. SALEEBA | 2022
Dans Drugs: Education, Prevention and Policy (Vol.29, n°1, February 2022) Article : Périodique

The 'social worlds' concept has been underutilized in alcohol research. This is surprising given that drinking is primarily a social activity, often a secondary part of a sociable occasion in a social world whose members come together around som[...]

Plus d'info

Ajouter à la sélection

Lien externe

Les infections à HBV et à HIV en milieu carcéral

J. BEYLOT ; M. BENEZECH ; D. LACOSTE ; RAGER P. ; DOUTRE M. S. ; M. L. BUESTEL ; K. TURNER | 1988
Périodique

Plus d'info

Ajouter à la sélection

Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease : a pilot study

J. BEARN ; A. EVANS ; M. KELLEHER ; K. TURNER ; A. LEES | 2004
Périodique

ENGLISH : Patients with Parkinson's disease may use Dopamine Replacement Therapy (DRT) in excess of therapeutic need. We investigate whether a group of 10 patients with Parkinson's disease, provisionally diagnosed with Hedonistic Homeostatic D[...]

Plus d'info

Ajouter à la sélection